ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
ThriftyClown
|
23 |
6.1K |
7 |
10:42 |
10:42 |
ASX - By Stock
|
23
|
6.1K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
ThriftyClown
|
232 |
52K |
33 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
232
|
52K
|
33
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
ThriftyClown
|
37 |
8.6K |
28 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
8.6K
|
28
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
ThriftyClown
|
58 |
16K |
9 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
58
|
16K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
ThriftyClown
|
196 |
36K |
9 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
196
|
36K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
ThriftyClown
|
126 |
31K |
21 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
126
|
31K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
ThriftyClown
|
209 |
49K |
16 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
209
|
49K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
ThriftyClown
|
323 |
75K |
30 |
24/02/24 |
24/02/24 |
ASX - By Stock
|
323
|
75K
|
30
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
ThriftyClown
|
197 |
51K |
10 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
197
|
51K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Best ASX stock Pharmaust for the next 10 years
|
|
ThriftyClown
|
9 |
2.6K |
24 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
9
|
2.6K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
MY INPUT REGARDING PAA AND SARS-COV-2.
|
|
ThriftyClown
|
41 |
9.0K |
18 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
41
|
9.0K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor Presentation and Non-Deal Roadshow
|
|
ThriftyClown
|
11 |
3.5K |
25 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
11
|
3.5K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
ThriftyClown
|
323 |
75K |
7 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
323
|
75K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
ThriftyClown
|
323 |
75K |
7 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
323
|
75K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
ThriftyClown
|
323 |
75K |
18 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
323
|
75K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
ThriftyClown
|
323 |
75K |
14 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
323
|
75K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
ThriftyClown
|
430 |
106K |
14 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
430
|
106K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Partners with Berry Consultants for MND Phase 2/3
|
|
ThriftyClown
|
98 |
23K |
16 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
98
|
23K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Partners with Berry Consultants for MND Phase 2/3
|
|
ThriftyClown
|
98 |
23K |
23 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
98
|
23K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Partners with Berry Consultants for MND Phase 2/3
|
|
ThriftyClown
|
98 |
23K |
21 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
98
|
23K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
ThriftyClown
|
430 |
106K |
22 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
430
|
106K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
ThriftyClown
|
430 |
106K |
30 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
430
|
106K
|
30
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Grants PharmAust Pre-IND Meeting
|
|
ThriftyClown
|
61 |
16K |
22 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
61
|
16K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust brand name required
|
|
ThriftyClown
|
30 |
6.0K |
11 |
30/12/23 |
30/12/23 |
ASX - By Stock
|
30
|
6.0K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust brand name required
|
|
ThriftyClown
|
30 |
6.0K |
8 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
30
|
6.0K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FightMND Invites PharmAust to Apply for Phase 2/3 Funding
|
|
ThriftyClown
|
56 |
15K |
14 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
56
|
15K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FightMND Invites PharmAust to Apply for Phase 2/3 Funding
|
|
ThriftyClown
|
56 |
15K |
20 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
56
|
15K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Receives R&D Tax Incentive Refund
|
|
ThriftyClown
|
1 |
650 |
21 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
1
|
650
|
21
|
|
ASX - By Stock
|
PAA Biotech |
Re:
FDA Application for Orphan Drug Designation , PAA, MPL
|
|
ThriftyClown
|
355 |
67K |
25 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
355
|
67K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Trial Centre Monepantel Pharmaust
|
|
ThriftyClown
|
8 |
1.9K |
23 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
8
|
1.9K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at Emerging ASX Gems Conference
|
|
ThriftyClown
|
82 |
17K |
14 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
82
|
17K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
FDA Application for Orphan Drug Designation , PAA, MPL
|
|
ThriftyClown
|
355 |
67K |
14 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
355
|
67K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final MND Patient in Cohort 4 Successfully Completes Dosing
|
|
ThriftyClown
|
125 |
24K |
20 |
13/10/23 |
13/10/23 |
ASX - By Stock
|
125
|
24K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Oncology Data Supports Progression to Registration
|
|
ThriftyClown
|
91 |
18K |
15 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
91
|
18K
|
15
|
|
Charts
|
PAA Biotech |
Re:
Mr Michael Thurn CEO Interview On Small Caps
|
|
ThriftyClown
|
57 |
15K |
8 |
24/09/23 |
24/09/23 |
Charts
|
57
|
15K
|
8
|
|
Charts
|
PAA Biotech |
Re:
Mr Michael Thurn CEO Interview On Small Caps
|
|
ThriftyClown
|
57 |
15K |
20 |
22/09/23 |
22/09/23 |
Charts
|
57
|
15K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Additional Phase 1 data suggest MPL may inhibit MND
|
|
ThriftyClown
|
380 |
83K |
16 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
380
|
83K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Chief Executive Officer Appointment
|
|
ThriftyClown
|
95 |
22K |
19 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
95
|
22K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Additional Phase 1 data suggest MPL may inhibit MND
|
|
ThriftyClown
|
380 |
83K |
10 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
380
|
83K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
ThriftyClown
|
78 |
20K |
15 |
20/08/23 |
20/08/23 |
ASX - By Stock
|
78
|
20K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Cohort 3 Pharmacokinetics in MND Patients Completed
|
|
ThriftyClown
|
140 |
31K |
13 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
140
|
31K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Cohort 3 Pharmacokinetics in MND Patients Completed
|
|
ThriftyClown
|
140 |
31K |
14 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
140
|
31K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem enters voluntary liquidation
|
|
ThriftyClown
|
218 |
50K |
14 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
218
|
50K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Results show MPL suppresses biomarkers associated with MND
|
|
ThriftyClown
|
200 |
41K |
31 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
200
|
41K
|
31
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
ThriftyClown
|
26 |
6.6K |
21 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
26
|
6.6K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
ThriftyClown
|
396 |
82K |
28 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
396
|
82K
|
28
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
ThriftyClown
|
396 |
82K |
24 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
396
|
82K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Commencement of Cohort 3 in Phase 1/2 MND Trial
|
|
ThriftyClown
|
151 |
31K |
11 |
13/06/23 |
13/06/23 |
ASX - By Stock
|
151
|
31K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust MND Trial Interim Analysis PK Outcomes
|
|
ThriftyClown
|
105 |
26K |
17 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
105
|
26K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Motor Neurone Disease Clinical Trial Update
|
|
ThriftyClown
|
147 |
34K |
11 |
02/06/23 |
02/06/23 |
ASX - By Stock
|
147
|
34K
|
11
|
|